郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

代谢疾病Agonism and antagonism at the insulin receptor.

期刊：PloS one发表年份：2012作者：Louise Knudsen; Bo Falck Hansen; Pia Jensen; Thomas Åskov Pedersen; Kirsten Vestergaard; Lauge Schäffer; Blagoy Blagoev; Martin B Oleksiewicz; Vladislav V Kiselyov; Pierre De Meyts
阅读更多 →

代谢疾病Pharmacological profile of ipragliflozin (ASP1941), a novel selective SGLT2 inhibitor, in vitro and in vivo.

期刊：Naunyn-Schmiedeberg's archives of pharmacology发表年份：2012作者：Atsuo Tahara; Eiji Kurosaki; Masanori Yokono; Daisuke Yamajuku; Rumi Kihara; Yuka Hayashizaki; Toshiyuki Takasu; Masakazu Imamura; Li Qun; Hiroshi Tomiyama; Yoshinori Kobayashi; Atsushi Noda; Masao Sasamata; Masayuki Shibasaki
阅读更多 →

代谢疾病Systematic evaluation of the metabolic to mitogenic potency ratio for B10-substituted insulin analogues.

期刊：PloS one发表年份：2012作者：Tine Glendorf; Louise Knudsen; Carsten E Stidsen; Bo F Hansen; Anne Charlotte Hegelund; Anders R Sørensen; Erica Nishimura; Thomas Kjeldsen
阅读更多 →

代谢疾病Synthesis, structure-activity relationship, and pharmacological studies of novel melanin-concentrating hormone receptor 1 antagonists 3-aminomethylquinolines: reducing human ether-a-go-go-related gene (hERG) associated liabilities.

期刊：Journal of medicinal chemistry发表年份：2012作者：Shizuo Kasai; Makoto Kamata; Shinichi Masada; Jun Kunitomo; Masahiro Kamaura; Tomohiro Okawa; Kazuaki Takami; Hitomi Ogino; Yoshihide Nakano; Shuntarou Ashina; Kaoru Watanabe; Tomoko Kaisho; Yumi N Imai; Sunghi Ryu; Masaharu Nakayama; Yasutaka Nagisa
阅读更多 →